Screening or treatment? Both!

Advances in screening and treatment are saving breast cancer patients’ lives. A recently published model-based analysis quantifies just how much of a difference these advances – seperately and combined – are making in reducing breast cancer mortality by molecular type.

Plevritis et al, Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012


The project was launched in September 2015 and will continue to August 2020.

This project has received funding from the European Unionʼs Horizon2020 Programme under grant agreement no 634753